PFE
Pfizer Inc
28.70$
+0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 78.6% | 59.0% | 29.4% | 37.9% | 39.2% | 27.0% | 28.3% | 35.7% | 25.1% | 30.0% | 32.7% | 27.2% | 28.7% | |
| 21.4% | 41.0% | 70.6% | 62.1% | 60.8% | 73.0% | 71.7% | 64.3% | 74.9% | 70.0% | 67.3% | 72.8% | 71.3% | |
| 19.9% | 19.0% | 16.7% | 20.1% | 14.5% | 17.0% | 15.9% | 16.7% | 23.6% | 19.5% | 18.2% | 18.7% | 20.1% | |
| 24.9% | 5.3% | 23.5% | 28.0% | 18.3% | 8.1% | 22.1% | 23.3% | 19.1% | 23.2% | 20.5% | 22.7% | 21.4% | |
| 43.7% | 49.7% | 39.9% | 47.9% | 32.8% | 40.8% | 37.9% | 39.9% | 53.6% | 49.0% | 39.4% | 41.5% | 46.2% | |
| -22.3% | -8.7% | 30.6% | 14.1% | 28.1% | 32.2% | 33.7% | 24.4% | 21.3% | 21.0% | 27.9% | 31.3% | 25.1% | |
| 5.2% | 4.7% | 5.3% | 5.9% | 4.4% | 4.2% | 4.8% | 4.5% | 3.9% | 4.0% | 4.6% | 4.4% | 4.2% | |
| -24.8% | -28.3% | 23.0% | -0.8% | 26.6% | -0.1% | 20.3% | 20.8% | 20.0% | -9.4% | 21.9% | -4.3% | 6.6% | |
| -7.1% | -5.4% | 2.0% | -1.0% | 1.3% | -2.4% | -1.4% | 1.0% | -1.3% | 0.0% | 3.2% | -2.7% | -0.3% | |
| -17.7% | -22.9% | 21.0% | 0.2% | 25.3% | 2.3% | 21.6% | 19.9% | 21.3% | -9.4% | 18.6% | -1.6% | 6.8% | |
| -8.1% | -12.1% | 40.0% | 18.1% | 41.0% | 29.0% | 36.9% | 36.3% | 33.9% | 4.3% | 34.7% | 8.0% | 19.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.